Financials Neusoft Xikang Holdings Inc.

Equities

9686

KYG6461A1094

Advanced Medical Equipment & Technology

End-of-day quote Hong Kong S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
0.88 USD 0.00% Intraday chart for Neusoft Xikang Holdings Inc. +3.53% -35.77%

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 503 614.3 687.4
EBITDA 1 -95.21 -244.2 -161.5
EBIT 1 -126.4 -261.9 -173.7
Operating Margin -25.13% -42.63% -25.27%
Earnings before Tax (EBT) 1 -203 -292.8 -238.3
Net income 1 -196.4 -296.5 -242
Net margin -39.05% -48.27% -35.2%
EPS 2 -0.3170 -0.4774 -0.3895
Free Cash Flow - 22.89 -46.66
FCF margin - 3.73% -6.79%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 9/17/23 9/17/23 9/17/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 10.1 75.8 208
Net Cash position 1 - - -
Leverage (Debt/EBITDA) -0.1059 x -0.3103 x -1.285 x
Free Cash Flow - 22.9 -46.7
ROE (net income / shareholders' equity) - 148% 68.2%
ROA (Net income/ Total Assets) - -17.2% -11.5%
Assets 1 - 1,723 2,097
Book Value Per Share 2 -0.2100 -0.4400 -0.7300
Cash Flow per Share 2 0.6300 0.5900 0.5600
Capex 1 107 18.4 7.34
Capex / Sales 21.24% 2.99% 1.07%
Announcement Date 9/17/23 9/17/23 9/17/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 9686 Stock
  4. Financials Neusoft Xikang Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW